Open AccessEndocrine and Metabolic Diseases Among Colorectal Cancer Survivors in a Population-Based Cohort
Author(s) -
Makenzie Hawkins,
Brenna Blackburn,
Kerry Rowe,
John Snyder,
Vikrant Deshmukh,
Michael G. Newman,
Alison Fraser,
Ken R. Smith,
Kimberly Herget,
Patricia A. Ganz,
N. Jewel Samadder,
Mia Hashibe
Publication year - 2019
Publication title -
journal of the national cancer institute
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.797
H-Index - 356
eISSN - 1460-2105
pISSN - 0027-8874
DOI - 10.1093/jnci/djz040
Subject(s) - medicine , hazard ratio , population , cohort , colorectal cancer , cohort study , proportional hazards model , risk factor , diabetes mellitus , confidence interval , cancer , endocrinology , environmental health
There are an estimated 1.4 million colorectal cancer (CRC) survivors in the United States. Research on endocrine and metabolic diseases over the long term in CRC survivors is limited. Obesity is a risk factor for CRC; thus it is of interest to investigate diseases that may share this risk factor, such as diabetes, for long-term health outcomes among CRC survivors.